Sol-Gel Technologies (SLGL) News Today → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free SLGL Stock Alerts $0.70 -0.05 (-6.68%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSol-Gel Technologies Ltd.wsj.com - April 20 at 5:36 PMSol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Creamglobenewswire.com - April 1 at 7:00 AMSol Gel Technologies Ltd (SLGL)investing.com - March 23 at 11:58 AMSLGL May 2024 2.500 putfinance.yahoo.com - March 16 at 1:25 PMSol-Gel Technologies: Q4 Earnings Insightsbenzinga.com - March 14 at 1:48 PMSol-Gel Technologies Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Linefinance.yahoo.com - March 14 at 8:47 AMSol-Gel Technologies Ltd.: Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developmentsfinanznachrichten.de - March 14 at 3:47 AMSol-Gel Reports Full-Year 2023 Financial Results and Corporate Developmentsglobenewswire.com - March 13 at 7:00 AMSol-Gel Technologies Ltd. (SLGL) stock forecast and price targetfinance.yahoo.com - February 28 at 9:43 AMSol-Gel Technologies Stock (NASDAQ:SLGL), Quotes and News Summarybenzinga.com - February 22 at 10:05 AMOptimistic Buy Rating for Sol-Gel Technologies on Revolutionary Topical Treatment SGT-610’s Market Potentialmarkets.businessinsider.com - December 9 at 3:48 AMSol-Gel Technologies Ltd.: Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Studyfinanznachrichten.de - November 30 at 6:30 PMSol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Studyfinance.yahoo.com - November 30 at 8:29 AMSol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610finance.yahoo.com - November 28 at 9:36 AMIs Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Trading At A 24% Discount?finance.yahoo.com - November 20 at 7:19 AMSol-Gel Technologies GAAP EPS of -$0.21 beats by $0.02, revenue of $0.21M misses by $0.48Mmsn.com - November 9 at 5:31 PMSol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 9 at 7:27 AMZacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologiesfinance.yahoo.com - October 31 at 9:35 AMIs Sol-Gel Technologies (NASDAQ:SLGL) In A Good Position To Invest In Growth?finance.yahoo.com - October 10 at 10:05 AMSol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - August 30 at 2:55 PMHC Wainwright & Co. Maintains Sol-Gel Technologies (SLGL) Buy Recommendationmsn.com - August 15 at 5:07 AMExpert Ratings for Sol-Gel Technologiesmarkets.businessinsider.com - August 11 at 4:26 PMSol-Gel Technologies Ltd. (SLGL) Reports Q2 Loss, Lags Revenue Estimatesfinance.yahoo.com - August 10 at 2:04 PMSol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 10 at 9:03 AMSol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Top Key Executive Moshe Arkin is the most upbeat insider, and their holdings increased by 15% last weekfinance.yahoo.com - July 21 at 7:40 AMRaymond James Maintains Sol-Gel Technologies (SLGL) Strong Buy Recommendationnasdaq.com - July 20 at 10:24 AMIsrael's Sol-Gel signs Canadian licensing deal for Twyneo, Eposolaymsn.com - June 6 at 3:38 PMH.C. Wainwright Sticks to Their Buy Rating for Sol-Gel Technologies (SLGL)markets.businessinsider.com - June 5 at 10:08 AMShareholders in Sol-Gel Technologies (NASDAQ:SLGL) are in the red if they invested five years agofinance.yahoo.com - June 2 at 10:29 AMSol-Gel Technologies Ltd.: Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - May 12 at 1:09 PMSol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Tops Revenue Estimatesfinance.yahoo.com - May 12 at 1:09 PMSol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - May 12 at 8:09 AMCompanies Like Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Invest In Growthfinance.yahoo.com - April 22 at 8:46 AMHC Wainwright & Co. Reiterates Sol-Gel Technologies (SLGL) Buy Recommendationmsn.com - April 13 at 9:36 AMH.C. Wainwright Keeps Their Buy Rating on Sol-Gel Technologies (SLGL)markets.businessinsider.com - April 12 at 8:41 AMSol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conferencefinance.yahoo.com - March 20 at 11:33 AMSol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conferencefinance.yahoo.com - March 20 at 11:33 AMSol-Gel Technologies Ltd.: Sol-Gel Reports Full-Year 2022 Financial Results and Corporate Developmentsfinanznachrichten.de - March 10 at 7:34 PMSol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Lags Revenue Estimatesfinance.yahoo.com - March 10 at 7:34 PMSol-Gel Reports Full-Year 2022 Financial Results and Corporate Developmentsfinance.yahoo.com - March 10 at 7:29 AMSLGL Sol-Gel Technologies Ltd.seekingalpha.com - February 28 at 12:47 PMCould The Market Be Wrong About Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Given Its Attractive Financial Prospects?finance.yahoo.com - February 27 at 8:09 AMSol-Gel Technologies Ltd. (NASDAQ:SLGL) Sees Large Drop in Short Interestmarketbeat.com - February 10 at 9:32 PMQ1 2023 Earnings Forecast for Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Issued By HC Wainwrightmarketbeat.com - February 3 at 7:18 AMSol-Gel to acquire rare disorder drug patidegib for $4.7M upfront; plans $22.8M offeringsmsn.com - January 27 at 1:06 PMSol-Gel Acquires Patidegib, a Phase 3, FDA-Breakthrough-Designated Orphan Product Candidate to Pursue Potential Market of Over $300 Millionfinance.yahoo.com - January 27 at 8:05 AMSol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offeringsfinance.yahoo.com - January 27 at 8:05 AMZacks Industry Outlook Highlights Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel Technologiesfinance.yahoo.com - December 8 at 1:46 PM3 Generic Drug Stocks to Watch Amid Inflation Pressuresfinance.yahoo.com - December 7 at 3:14 PMFY2022 EPS Estimates for Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Cut by HC Wainwrightmarketbeat.com - November 16 at 8:05 AM Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here SLGL Media Mentions By Week SLGL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLGL News Sentiment▼1.440.51▲Average Medical News Sentiment SLGL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLGL Articles This Week▼20▲SLGL Articles Average Week Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BioVie News Alaunos Therapeutics News KALA BIO News MEI Pharma News Synlogic News Onconova Therapeutics News Aptorum Group News Galecto News Indaptus Therapeutics News NeuroSense Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLGL) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCollapse of the Petrodollar Colonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.